Legal & General Group
MLAB icon

Legal & General Group’s Mesa Laboratories MLAB Stock Holding History

Legal & General Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8K Buy
520
+51
+11% +$5.13K ﹤0.01% 2753
2026
Q1 		$41.5K Sell
469
-79
-14% -$6.81K ﹤0.01% 2722
2025
Q4 		$43K Sell
548
-26
-5% -$1.98K ﹤0.01% 2766
2025
Q3 		$38.5K Sell
574
-14,083
-96% -$1.01M ﹤0.01% 2801
2025
Q2 		$1.38M Buy
14,657
+746
+5% +$81.9K ﹤0.01% 2130
2025
Q1 		$1.65M Sell
13,911
-376
-3% -$51.3K ﹤0.01% 2000
2024
Q4 		$1.88M Sell
14,287
-925
-6% -$114K ﹤0.01% 1996
2024
Q3 		$1.98M Buy
15,212
+127
+0.8% +$14.9K ﹤0.01% 1975
2024
Q2 		$1.31M Sell
15,085
-45
-0.3% -$4.71K ﹤0.01% 2105
2024
Q1 		$1.66M Sell
15,130
-68
-0.4% -$6.85K ﹤0.01% 2006
2023
Q4 		$1.59M Sell
15,198
-152
-1% -$14.8K ﹤0.01% 2058
2023
Q3 		$1.61M Buy
15,350
+1,153
+8% +$148K ﹤0.01% 1990
2023
Q2 		$1.82M Buy
14,197
+1,646
+13% +$251K ﹤0.01% 1969
2023
Q1 		$2.19M Sell
12,551
-122
-1% -$21.9K ﹤0.01% 1846
2022
Q4 		$2.11M Buy
12,673
+323
+3% +$50.6K ﹤0.01% 1858
2022
Q3 		$1.74M Sell
12,350
-478
-4% -$87.2K ﹤0.01% 1933
2022
Q2 		$2.62M Buy
12,828
+103
+0.8% +$22.6K ﹤0.01% 1740
2022
Q1 		$3.24M Sell
12,725
-74
-0.6% -$20.1K ﹤0.01% 1767
2021
Q4 		$4.2M Buy
12,799
+673
+6% +$211K ﹤0.01% 1670
2021
Q3 		$3.67M Buy
12,126
+1,596
+15% +$454K ﹤0.01% 1716
2021
Q2 		$2.85M Sell
10,530
-3,323
-24% -$843K ﹤0.01% 1820
2021
Q1 		$3.37M Buy
13,853
+68
+0.5% +$18.7K ﹤0.01% 1763
2020
Q4 		$3.95M Sell
13,785
-63
-0.5% -$17.3K ﹤0.01% 1583
2020
Q3 		$3.53M Buy
13,848
+2,324
+20% +$552K ﹤0.01% 1513
2020
Q2 		$2.5M Buy
11,524
+881
+8% +$203K ﹤0.01% 1639
2020
Q1 		$2.41M Buy
10,643
+42
+0.4% +$10.4K ﹤0.01% 1498
2019
Q4 		$2.64M Buy
10,601
+797
+8% +$187K ﹤0.01% 1660
2019
Q3 		$2.33M Buy
9,804
+3,317
+51% +$767K ﹤0.01% 1655
2019
Q2 		$1.58M Buy
6,487
+5,809
+857% +$1.35M ﹤0.01% 1797
2019
Q1 		$157K Buy
678
+22
+3% +$4.97K ﹤0.01% 2377
2018
Q4 		$136K Buy
656
+81
+14% +$15.8K ﹤0.01% 2392
2018
Q3 		$107K Hold
575
– – ﹤0.01% 2496
2018
Q2 		$122K Buy
575
+24
+4% +$4.2K ﹤0.01% 2433
2018
Q1 		$82K Sell
551
-256
-32% -$34.9K ﹤0.01% 2535
2017
Q4 		$100K Sell
807
-21
-3% -$2.94K ﹤0.01% 2584
2017
Q3 		$123K Sell
828
-72
-8% -$10.2K ﹤0.01% 2533
2017
Q2 		$128K Hold
900
– – ﹤0.01% 2477
2017
Q1 		$110K Sell
900
-7
-0.8% -$857 ﹤0.01% 2488
2016
Q4 		$111K Buy
907
+376
+71% +$46.9K ﹤0.01% 2497
2016
Q3 		$59K Hold
531
– – ﹤0.01% 2440
2016
Q2 		$64K Hold
531
– – ﹤0.01% 2339
2016
Q1 		$50K Hold
531
– – ﹤0.01% 2411
2015
Q4 		$52K Hold
531
– – ﹤0.01% 2441
2015
Q3 		$56K Hold
531
– – ﹤0.01% 2386
2015
Q2 		$48K Hold
531
– – ﹤0.01% 2554
2015
Q1 		$38K Hold
531
– – ﹤0.01% 2601
2014
Q4 		$42K Hold
531
– – ﹤0.01% 2509
2014
Q3 		$30K Buy
+531
New +$38.5K ﹤0.01% 2578

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Legal & General Group's MLAB Position: Q2 2026 in Review

Legal & General Group increased its Mesa Laboratories (MLAB) stake by 11% in Q2 2026, buying an estimated $5.13K and bringing the position to 520 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Legal & General Group first reported a position in MLAB in Q3 2014 and has held it in 48 quarters since. The position peaked at $4.2M in Q4 2021. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Legal & General Group held 520 shares of Mesa Laboratories worth $51.8K as of Q2 2026.
  • Legal & General Group bought 51 Mesa Laboratories shares in Q2 2026, an estimated $5.13K.
  • Mesa Laboratories made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2753 holding.
  • Legal & General Group first reported a position in Mesa Laboratories in Q3 2014 and has held it in 48 quarters since.
  • Legal & General Group's Mesa Laboratories position peaked at $4.2M in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.